Markus Flepp
- Virology top 0.1%
- HIV Research and Treatment 32
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 39
- HIV/AIDS Research and Interventions 32
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 8
- Hepatology top 1%
- Hepatitis C virus research 5
- Epidemiology top 1%
- Pneumocystis jirovecii pneumonia detection and treatment 8
- HIV, Drug Use, Sexual Risk 5
- Cytomegalovirus and herpesvirus research 5
- Co-authors
- Pietro VernazzaAmalio TelentiBernard HirschelHansjakob FurrerP FrancioliBruno LedergerberMartin RickenbachMatthias Egger
- Journals
- AIDS (11 papers)Clinical Infectious Diseases (5 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (4 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Markus Flepp
72 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Virology 2.8k
- Infectious Diseases 4.1k
- Emergency Medicine 1.0k
- Hepatology 789
- Epidemiology 2.0k
Countries citing papers authored by Markus Flepp
This map shows the geographic impact of Markus Flepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Flepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Flepp more than expected).
Fields of papers citing papers by Markus Flepp
This network shows the impact of papers produced by Markus Flepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Flepp. The network helps show where Markus Flepp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Flepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2019 | 51 | |
| 3 | 2010 | 6 | |
| 4 | 2009 | 24 | |
| 5 | 2009 | 84 | |
| 6 | 2008 | 27 | |
| 7 | 2008 | 195 | |
| 8 | 2008 | 0 | |
| 9 | 2006 | 11 | |
| 10 | 2004 | 24 | |
| 11 | 2002 | 21 | |
| 12 | 2001 | 15 | |
| 13 | 2001 | 259 | |
| 14 | 2000 | 30 | |
| 15 | 2000 | 61 | |
| 16 | Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Studybreakdown → | 2000 | 692 |
| 17 | Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued ? | 1999 | 38 |
| 18 | 1996 | 7 | |
| 19 | 1989 | 4 | |
| 20 | [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]. | 1986 | 2 |
About Markus Flepp
Markus Flepp is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Parasitology and Epidemiology, having authored 74 papers that have together received 5.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (39 papers), HIV Research and Treatment (32 papers), HIV/AIDS Research and Interventions (32 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), HIV-related health complications and treatments (8 papers), HIV, Drug Use, Sexual Risk (5 papers), Hepatitis C virus research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Virology (2.8k citations), Infectious Diseases (4.1k citations), Emergency Medicine (1.0k citations), Hepatology (789 citations) and Epidemiology (2.0k citations). Markus Flepp has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Pietro Vernazza, Amalio Telenti, Bernard Hirschel, Hansjakob Furrer, P Francioli, Bruno Ledergerber, Martin Rickenbach, Matthias Egger, Philippe Sudre and Rainer Weber. Their work appears in journals such as AIDS, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Agents and Chemotherapy and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.